Lee's Pharma to Market Solasia's Anti-Nausea Patch in China

Lee’s Pharma has acquired China commercialization rights to an anti-nausea from Solasia Pharma of Tokyo. Sancuso ® is a patch-delivery of granisetron, used to treat the nausea and vomiting caused by chemotherapy. Solasia will retain Sancuso distribution rights in Beijing, Shanghai and Guangzhou, while Lee's will market the drug in the rest of mainland China. Solasia submitted an NDA for CFDA approval of Sancuso in June 2014. More details.... Stock Symbol: (HK: 0950) Share this with colleagues: // //